SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-12-024374
Filing Date
2012-04-09
Accepted
2012-04-09 16:16:28
Documents
5
Effectiveness Date
2012-04-09

Document Format Files

Seq Description Document Type Size
1 DEFA14A a12-1817_3defa14a.htm DEFA14A 36449
2 GRAPHIC g18173bci001.gif GRAPHIC 86017
3 GRAPHIC g18173bci002.gif GRAPHIC 84979
4 GRAPHIC g18173bci003.gif GRAPHIC 51958
5 GRAPHIC g18173bci004.gif GRAPHIC 45699
  Complete submission text file 0001104659-12-024374.txt   408285
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-31812 | Film No.: 12749847
SIC: 2836 Biological Products, (No Diagnostic Substances)